Subcortical Neuronal Correlates of Sleep in Neurodegenerative Diseases.


Journal

JAMA neurology
ISSN: 2168-6157
Titre abrégé: JAMA Neurol
Pays: United States
ID NLM: 101589536

Informations de publication

Date de publication:
01 05 2022
Historique:
pubmed: 5 4 2022
medline: 12 5 2022
entrez: 4 4 2022
Statut: ppublish

Résumé

Sleep disturbance is common among patients with neurodegenerative diseases. Examining the subcortical neuronal correlates of sleep disturbances is important to understanding the early-stage sleep neurodegenerative phenomena. To examine the correlation between the number of important subcortical wake-promoting neurons and clinical sleep phenotypes in patients with Alzheimer disease (AD) or progressive supranuclear palsy (PSP). This longitudinal cohort study enrolled 33 patients with AD, 20 patients with PSP, and 32 healthy individuals from the Memory and Aging Center of the University of California, San Francisco, between August 22, 2008, and December 31, 2020. Participants received electroencephalographic and polysomnographic sleep assessments. Postmortem neuronal analyses of brainstem hypothalamic wake-promoting neurons were performed and were included in the clinicopathological correlation analysis. No eligible participants were excluded from the study. Electroencephalographic and polysomnographic assessment of sleep and postmortem immunohistological stereological analysis of 3 wake-promoting nuclei (noradrenergic locus coeruleus [LC], orexinergic lateral hypothalamic area [LHA], and histaminergic tuberomammillary nucleus [TMN]). Nocturnal sleep variables, including total sleep time, sleep maintenance, rapid eye movement (REM) latency, and time spent in REM sleep and stages 1, 2, and 3 of non-REM (NREM1, NREM2, and NREM3, respectively) sleep, and wake after sleep onset. Neurotransmitter, tau, and total neuronal counts of LC, LHA, and TMN. Among 19 patients included in the clinicopathological correlation analysis, the mean (SD) age at death was 70.53 (7.75) years; 10 patients (52.6%) were female; and all patients were White. After adjusting for primary diagnosis, age, sex, and time between sleep analyses and death, greater numbers of LHA and TMN neurons were correlated with decreased homeostatic sleep drive, as observed by less total sleep time (LHA: r = -0.63; P = .009; TMN: r = -0.62; P = .008), lower sleep maintenance (LHA: r = -0.85; P < .001; TMN: r = -0.78; P < .001), and greater percentage of wake after sleep onset (LHA: r = 0.85; P < .001; TMN: r = 0.78; P < .001). In addition, greater numbers of LHA and TMN neurons were correlated with less NREM2 sleep (LHA: r = -0.76; P < .001; TMN: r = -0.73; P < .001). A greater number of TMN neurons was also correlated with less REM sleep (r = -0.61; P = .01). A greater number of LC neurons was mainly correlated with less total sleep time (r = -0.68; P = .008) and greater REM latency (r = 0.71; P = .006). The AD-predominant group had significantly greater sleep drive, including higher total sleep time (mean [SD], 0.49 [1.18] vs -1.09 [1.37]; P = .03), higher sleep maintenance (mean [SD], 0.18 [1.22] vs -1.53 [1.78]; P = .02), and lower percentage of wake after sleep onset during sleep period time (mean [SD], -0.18 [1.20] vs 1.49 [1.72]; P = .02) than the PSP-predominant group based on unbiased k-means clustering and principal component analyses. In this cohort study, subcortical wake-promoting neurons were significantly correlated with sleep phenotypes in patients with AD and PSP, suggesting that the loss of wake-promoting neurons among patients with neurodegenerative conditions may disturb the control of sleep-wake homeostasis. These findings suggest that the subcortical system is a primary mechanism associated with sleep disturbances in the early stages of neurodegenerative diseases.

Identifiants

pubmed: 35377391
pii: 2790494
doi: 10.1001/jamaneurol.2022.0429
pmc: PMC8981071
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

498-508

Subventions

Organisme : NIA NIH HHS
ID : K24 AG053435
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG060477
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG032289
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062422
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG019724
Pays : United States
Organisme : NIA NIH HHS
ID : K08 AG052648
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG064314
Pays : United States

Références

Neurology. 1996 Jul;47(1):1-9
pubmed: 8710059
Anat Rec. 1991 Dec;231(4):482-97
pubmed: 1793176
Sleep. 2018 Oct 1;41(10):
pubmed: 30192978
Brain Pathol. 2016 May;26(3):371-86
pubmed: 26193084
Alzheimers Dement. 2019 Oct;15(10):1253-1263
pubmed: 31416793
PLoS Med. 2017 Mar 28;14(3):e1002267
pubmed: 28350821
JAMA Neurol. 2018 Aug 1;75(8):1008-1012
pubmed: 29710120
JAMA Neurol. 2014 Dec;71(12):1498-505
pubmed: 25322206
Ann Neurol. 2020 May;87(5):700-709
pubmed: 32057125
Acta Neuropathol. 2007 Jul;114(1):5-22
pubmed: 17579875
J Alzheimers Dis. 2018;66(1):115-126
pubmed: 30223398
Neurobiol Dis. 2020 Oct;144:105031
pubmed: 32738506
Lancet Neurol. 2019 Mar;18(3):307-318
pubmed: 30784558
JAMA Neurol. 2013 May;70(5):587-93
pubmed: 23479184
Ann Neurol. 2015 Aug;78(2):317-22
pubmed: 25921596
Mov Disord. 2020 Jun;35(6):984-993
pubmed: 32125724
Arch Neurol. 1964 Apr;10:333-59
pubmed: 14107684
Sci Transl Med. 2019 Jan 9;11(474):
pubmed: 30626715
Alzheimers Dement. 2017 Mar;13(3):236-246
pubmed: 27513978
Dement Geriatr Cogn Dis Extra. 2015 Jul 10;5(2):286-95
pubmed: 26273244
Curr Opin Neurobiol. 2017 Jun;44:186-192
pubmed: 28577468
Exp Mol Med. 2015 Mar 13;47:e148
pubmed: 25766617
J Clin Sleep Med. 2007 Dec 15;3(7):752
pubmed: 18198811
Science. 2009 Nov 13;326(5955):1005-7
pubmed: 19779148
Curr Opin Physiol. 2020 Jun;15:210-216
pubmed: 32467862
Sleep Med Rev. 2021 Dec;60:101541
pubmed: 34500400
Mol Psychiatry. 2019 Sep;24(9):1284-1295
pubmed: 30377299
Am J Geriatr Psychiatry. 2014 Nov;22(11):1262-71
pubmed: 23954041
Sci Transl Med. 2021 Sep 22;13(612):eabj2511
pubmed: 34550726
Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S29-33
pubmed: 26382841
Science. 2019 Feb 22;363(6429):880-884
pubmed: 30679382
Alzheimers Dement. 2021 Aug;17(8):1403-1406
pubmed: 33710762
Brain. 2014 Oct;137(Pt 10):2847-61
pubmed: 25142380
Sleep Med Rev. 2015 Feb;19:29-38
pubmed: 24846773
Science. 2016 Nov 25;354(6315):1004-1008
pubmed: 27885006
Ann Neurol. 2016 Dec;80(6):858-870
pubmed: 27696483
Science. 2013 Oct 18;342(6156):373-7
pubmed: 24136970
Neuropsychopharmacology. 2020 Jan;45(1):104-120
pubmed: 31408876
Nat Neurosci. 2015 Jul;18(7):1051-7
pubmed: 26030850
Sleep. 2017 Nov 1;40(11):
pubmed: 29029214
Alzheimers Dement. 2019 Aug;15(8):1039-1047
pubmed: 31227429
Alzheimers Dement. 2012 Jan;8(1):1-13
pubmed: 22265587
Curr Alzheimer Res. 2013 Sep;10(7):767-75
pubmed: 23905991
Neuron. 2017 Feb 22;93(4):747-765
pubmed: 28231463
Sci Transl Med. 2012 Sep 5;4(150):150ra122
pubmed: 22956200
Neuropathol Appl Neurobiol. 2017 Aug;43(5):393-408
pubmed: 28117917
Sleep Med Clin. 2016 Mar;11(1):1-18
pubmed: 26972029

Auteurs

Jun Y Oh (JY)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.
School of Medicine, University of California, San Francisco, San Francisco.

Christine M Walsh (CM)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Kamalini Ranasinghe (K)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Mihovil Mladinov (M)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Felipe L Pereira (FL)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Cathrine Petersen (C)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Neus Falgàs (N)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.
Global Brain Health Institute, University of California, San Francisco, San Francisco.

Leslie Yack (L)

Stress and Health Research Program, Department of Mental Health, San Francisco VA Medical Center, San Francisco, California.

Tia Lamore (T)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Rakin Nasar (R)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Caroline Lew (C)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Song Li (S)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Thomas Metzler (T)

Stress and Health Research Program, Department of Mental Health, San Francisco VA Medical Center, San Francisco, California.

Quentin Coppola (Q)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Natalie Pandher (N)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Michael Le (M)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Hilary W Heuer (HW)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Helmut Heinsen (H)

Department of Psychiatry, University of Wurzburg, Wurzburg, Germany.

Salvatore Spina (S)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

William W Seeley (WW)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Joel Kramer (J)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Gil D Rabinovici (GD)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Adam L Boxer (AL)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.

Bruce L Miller (BL)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.
Global Brain Health Institute, University of California, San Francisco, San Francisco.

Keith Vossel (K)

Department of Neurology, University of California, Los Angeles, Los Angeles.

Thomas C Neylan (TC)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.
Stress and Health Research Program, Department of Mental Health, San Francisco VA Medical Center, San Francisco, California.
Department of Psychiatry, University of California, San Francisco, San Francisco.

Lea T Grinberg (LT)

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco.
Global Brain Health Institute, University of California, San Francisco, San Francisco.
Department of Pathology, University of Sao Paulo Medical School, Sao Paulo, Brazil.
Department of Pathology, University of California, San Francisco, San Francisco.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH